Effect Of Unani Formulation in Oligomenorrhoea - An Observational Study

Oligomenorrhoea can only be defined arbitrarily as one in which the cycle last longer than 35days. Menstruation may be both infrequent & irregular or may be regularly infrequent. Oligomenorrhoea with a prevalence of 12-15.3% in different studies around the world, is one of the most common type of menstrual bleeding disorder. It is estimated that oligomenorrhoea has prevalence of approximately 10.2% among women of reproductive age group. Oligomenorrhoea is often associated with PCOS which is the most common endocrine disorder in women. Anovulationis present in 60% of women with oligomenorrhoea. Hormone imbalances such as anovulation & androgen excess disorders such as PCOS, adrenal hyperplasia, hyperprolactinemia and thyroid function disorders are the most important causes of oligomenorrhoea.Complications caused by oligomenorrhoea such as infertility, low fertility, malignancies, cardiovascular diseases , diabetes mellitus, hirsutism & acne vulgaris result in problems regarding women’s general health & quality of life. Therefore, timely diagnosis & treatment of these disorders are of utmost important. Hormone therapy is the main treatment of oligomenorrhoea in western or conventional medicine, however the result of a study on infertile women with oligomenorrhoea and PCOD revealed that only 25.6 % of them has good compliance to this treatment, although effective but have their own side effects.Therefore there is need for alternate therapy.

Several drugs are prescribed for qillate tams in unani system of medicine which can be used for treatment. The drug possessing the properties of musaff-i-khoon, mulattife-i-khoon, mudirr-i- bawl wa haiz, munzij balgham and mufatteh sudad etc. are used and are easily available, safe and cost effective. Hence there is need to evaluate the efficacy of unani formulation in qillate tams**.** Keeping all these facts in view, it has been decided to conduct a clinical study on qillate tams to evaluate the efficacy  of unani formulation